Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of AOC 1020 Administered Intravenously to Adult Patients with Facioscapulohumeral Muscular Dystrophy (FORTITUDE) Trial Design

              Author:Halseth, Amy   Ackermann, Elizabeth   Brandt, Teresa   Chen, Chao-Yin   Stahl, Mark   Ditrapani, Kelly   Hughes, Steve   Tawil, Alrabi   Statland, Jeffrey   

              Session Name:P3: Neuromuscular Disease: Inherited Muscle Disorders 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P3.007  

              Author Institution:Avidity Biosciences, San Diego, CA  Avidity Biosciences, La Jolla, CA  Avidity Biosciences, HALF MOON BAY, CA  University of Rochester Medical Center, Rochester, NY  University of Kansas Medical Center, Kansas City, KS